{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:01:31Z","timestamp":1786636891013,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/2230-8210.105583","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T02:29:23Z","timestamp":1357266563000},"page":"637","source":"Crossref","is-referenced-by-count":9,"title":["Benefits of leptin therapy in HIV patients"],"prefix":"10.4103","volume":"16","author":[{"given":"Uma","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshab","family":"Sinharay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.105583-1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Clinical review 159: Human immunodeficiency virus\/highly active antiretroviral therapy-associated metabolic syndrome: Clinical presentation, pathophysiology, and therapeutic strategies","author":"Leow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.105583-3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00002030-200102160-00005","article-title":"; Swiss HIV Cohort Study.2001 Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy","author":"Depairon","year":"2001","journal-title":"AIDS"},{"key":"key-10.4103\/2230-8210.105583-4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"key-10.4103\/2230-8210.105583-5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","article-title":"Weight-reducing effects of the plasma protein encoded by the obese gene","author":"Halaas","year":"1995","journal-title":"Science"},{"key":"key-10.4103\/2230-8210.105583-6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"key-10.4103\/2230-8210.105583-7","doi-asserted-by":"crossref","unstructured":"Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9.","DOI":"10.1126\/science.7624778"},{"key":"key-10.4103\/2230-8210.105583-8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0597-575","article-title":"Human leptin levels are pulsatile and inversely related to pituitary-adrenal function","author":"Licinio","year":"1997","journal-title":"Nat Med"},{"key":"key-10.4103\/2230-8210.105583-9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/endo.143.3.8669","article-title":"Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity","author":"Hileman","year":"2002","journal-title":"Endocrinology"},{"key":"key-10.4103\/2230-8210.105583-10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa063988","article-title":"Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor","author":"Farooqi","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.105583-11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng0398-213","article-title":"A leptin missense mutation associated with hypogonadism and morbid obesity","author":"Strobel","year":"1998","journal-title":"Nat Genet"},{"key":"key-10.4103\/2230-8210.105583-12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2230-8210.105583-13","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","author":"Javor","year":"2005","journal-title":"Diabetes"},{"key":"key-10.4103\/2230-8210.105583-14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.105583-15","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1073\/pnas.95.20.11852","article-title":"Abnormal regulation of the leptin gene in the pathogenesis of obesity","author":"Ioffe","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2230-8210.105583-16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects","author":"Maffei","year":"1995","journal-title":"Nat Med"},{"key":"key-10.4103\/2230-8210.105583-17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.peptides.2007.10.017","article-title":"Central leptin insufficiency syndrome: An interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions","author":"Kalra","year":"2008","journal-title":"Peptides"},{"key":"key-10.4103\/2230-8210.105583-18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1203\/00006450-200208000-00010","article-title":"Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: Effects on serum ghrelin and appetite regulating genes","author":"Beretta","year":"2002","journal-title":"Pediatr Res"},{"key":"key-10.4103\/2230-8210.105583-19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/oby.2006.115","article-title":"Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones","author":"Boghossian","year":"2006","journal-title":"Obesity"},{"key":"key-10.4103\/2230-8210.105583-20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diabetes.48.7.1487","article-title":"Leptin restores euglycemia and normalizes glucose turnover in insulin- deficient diabetes in the rat","author":"Chinookoswong","year":"1999","journal-title":"Diabetes"},{"key":"key-10.4103\/2230-8210.105583-21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/gt.2010.164","article-title":"Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: A new therapeutic intervention?","author":"Kalra","year":"2011","journal-title":"Gene Ther"},{"key":"key-10.4103\/2230-8210.105583-22","first-page":"141","article-title":"Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications","author":"Tsiodras","year":"2006","journal-title":"Am J Infect Dis"},{"key":"key-10.4103\/2230-8210.105583-23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2230-8210.105583-24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: A randomized controlled trial","author":"Koutkia","year":"2004","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.105583-25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention and treatment","author":"Simon","year":"2006","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.105583-26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/cs0940479","article-title":"Plasma leptin in chronic inflammatory bowel disease and HIV: Implications for the pathogenesis of anorexia and weight loss","author":"Ballinger","year":"1998","journal-title":"Clin Sci"},{"key":"key-10.4103\/2230-8210.105583-27","first-page":"162","article-title":"Serum Leptin Levels in Antiretroviral Therapy Na\u00efve HIV-1 Infected Patients in Zaria, Nigeria","author":"Onyemelukwe","year":"2009","journal-title":"Int J Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-28","first-page":"4342","article-title":"Serum leptin levels in Acquired immunodeficiency syndrome","author":"Grunfeld","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1086\/314963","article-title":"Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock","author":"Arnalich","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2230-8210.105583-30","first-page":"758","article-title":"Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation","author":"Van","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-31","first-page":"1293","article-title":"The metabolic significance of leptin in hhuman: Gender based differences in relationship to adiposity, insulin sensitivity and energy expenditure","author":"Kennedy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.189.1.51","article-title":"The HIV-1 virion-associated protein VPR is a coactivator of the human glucocorticoid receptor","author":"Kino","year":"1999","journal-title":"J Exp Med"},{"key":"key-10.4103\/2230-8210.105583-33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1196\/annals.1321.013","article-title":"Human immunodeficiency virus type 1 accessory protein Vpr: A causative agent of the AIDS-related insulin resistance\/lipodystrophy syndrome?","author":"Kino","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"key-10.4103\/2230-8210.105583-34","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","author":"Rietschel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","author":"Engelson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/2230-8210.105583-36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem.87.2.8391","article-title":"Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation","author":"Schwarz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"key-10.4103\/2230-8210.105583-39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1464-2662.2001.00073.x","article-title":"NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: Fact or fiction?","author":"Walker","year":"2001","journal-title":"HIV Med"},{"key":"key-10.4103\/2230-8210.105583-40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/135965350100603S01","article-title":"An introduction to nucleoside and nucleotide analogues","author":"Squires","year":"2001","journal-title":"Antivir Ther"},{"key":"key-10.4103\/2230-8210.105583-41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/135965350300800514","article-title":"Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells","author":"Walker","year":"2003","journal-title":"Antivir Ther"},{"key":"key-10.4103\/2230-8210.105583-42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-200202010-00002","article-title":"Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients","author":"Walker","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/2230-8210.105583-43","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/135965350701200704","article-title":"Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors","author":"Venhoff","year":"2007","journal-title":"Antivir Ther"},{"key":"key-10.4103\/2230-8210.105583-44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/135965350501000202","article-title":"Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors","author":"Jones","year":"2005","journal-title":"Antivir Ther"},{"key":"key-10.4103\/2230-8210.105583-45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350300800509","article-title":"Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes","author":"Janneh","year":"2003","journal-title":"Antivir Ther"},{"key":"key-10.4103\/2230-8210.105583-46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/oby.2006.114","article-title":"HIV protease inhibitor specific alterations in human adipocyte differentiation and metabolism","author":"Kim","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"key-10.4103\/2230-8210.105583-47","first-page":"1813","article-title":"Effects of atazanavir\/ritonavir and lopinavir\/ritonavir on glucose uptake and insulin sensitivity: Demonstrable differences in vitro and clinically","author":"Noor","year":"2006","journal-title":"Acquir Immune Defic Syndr"},{"key":"key-10.4103\/2230-8210.105583-48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2004.12.007","article-title":"HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo","author":"Lagathu","year":"2005","journal-title":"Biochimie"},{"key":"key-10.4103\/2230-8210.105583-49","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1124\/mol.104.010165","article-title":"Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors","author":"Parker","year":"2005","journal-title":"Mol Pharmacol"},{"key":"key-10.4103\/2230-8210.105583-50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0028-1082048","article-title":"Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: Time course of glucose homeostasis in leptin replacement treatment","author":"Andreev","year":"2009","journal-title":"Horm Metab Res"},{"key":"key-10.4103\/2230-8210.105583-51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy","author":"Javor","year":"2005","journal-title":"Hepatology"},{"key":"key-10.4103\/2230-8210.105583-53","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methinoyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-54","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with HIV-associated lipoatrophy and hypoleptinemia","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.105583-55","doi-asserted-by":"crossref","first-page":"991S","DOI":"10.3945\/ajcn.2008.26788E","article-title":"Leptin in humans: Lessons from translational research","author":"Bluher","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"key-10.4103\/2230-8210.105583-56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.300.5.509","article-title":"Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: A randomized controlled trial","author":"Lo","year":"2008","journal-title":"JAMA"},{"key":"key-10.4103\/2230-8210.105583-57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00126334-200403010-00004","article-title":"Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients","author":"Kotler","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/2230-8210.105583-58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: A 2 _ 2 factorial, randomized, double-blinded, placebocontrolled trial","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2230-8210.105583-59","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.105583-60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-08-0597","article-title":"r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: Observational and interventional studies in humans","author":"Brennan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.105583-61","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1210\/en.2003-1513","article-title":"Adiponectin and HIV-lipodystrophy: Taking HAART","author":"Kinlaw","year":"2004","journal-title":"Endocrinology"},{"key":"key-10.4103\/2230-8210.105583-62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/138955707779317821","article-title":"Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome","author":"Kralisch","year":"2007","journal-title":"Mini Rev Med Chem"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:02:26Z","timestamp":1786633346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2230-8210.105583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"alternative-id":["105583"],"URL":"https:\/\/doi.org\/10.4103\/2230-8210.105583","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}